David van Klaveren

9.1k citations

121 papers · 4.5k indexed · 4 hit papers · h-index 32

Cardiology and Cardiovascular Medicine top 1%
Surgery top 2%
Radiology, Nuclear Medicine and Imaging top 2%
Pulmonary and Respiratory Medicine top 5%
Epidemiology top 5%

Co-authors: Ewout W. Steyerberg David M. Kent Patrick W. Serruys Antonio Colombo Yvonne Vergouwe Gregg W. Stone Yoshinobu Onuma Peter C. Austin
Topics: Health Systems, Economic Evaluations, Quality of Life (23 papers)Coronary Interventions and Diagnostics (20 papers)Statistical Methods in Clinical Trials (11 papers)
Cited by: Cardiology and Cardiovascular Medicine Internal Medicine Statistics and Probability
Journals: The Lancet Nature CommunicationsSHILAP Revista de lepidopterología
Partner nations: Netherlands United States United Kingdom

In The Last Decade

David van Klaveren

110 papers receiving 4.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials

2017 659 citations David van Klaveren, Ewout W. Steyerberg et al. profile →
Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II

2013 503 citations David van Klaveren, Ewout W. Steyerberg et al. profile →
Personalized evidence based medicine: predictive approaches to heterogeneous treatment effects

2018 258 citations David M. Kent, Ewout W. Steyerberg et al. profile →
The Predictive Approaches to Treatment effect Heterogeneity (PATH) Statement

2019 220 citations David M. Kent, Jessica K. Paulus et al. profile →

Peers

Countries citing papers authored by David van Klaveren

Since Specialization

Citations

This map shows the geographic impact of David van Klaveren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David van Klaveren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David van Klaveren more than expected).

Fields of papers citing papers by David van Klaveren

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David van Klaveren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David van Klaveren. The network helps show where David van Klaveren may publish in the future.

Co-authorship network of co-authors of David van Klaveren

This figure shows the co-authorship network connecting the top 25 collaborators of David van Klaveren. A scholar is included among the top collaborators of David van Klaveren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David van Klaveren. David van Klaveren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Accuracy of Predicting Residual Disease and Disease Progression During Active Surveillance for Esophageal Cancer 2025 ·Annals of Surgical Oncology ·(unknown),David van Klaveren,Sjoerd M. Lagarde,Hester F. Lingsma,Bianca Mostert,Peter‐Paul L. O. Coene,Jan Willem T. Dekker,Henk H. Hartgrink,Joos Heisterkamp,Merlijn Hutteman,Ewout A. Kouwenhoven,Grard A. P. Nieuwenhuijzen,(unknown),Johanna W. van Sandick,Meindert N. Sosef,Edwin S. van der Zaag,J. Jan B. van Lanschot,Bas P. L. Wijnhoven,(unknown)	0
2	252. ACCURACY OF PREDICTING RESIDUAL DISEASE AND DISEASE PROGRESSION DURING ACTIVE SURVEILLANCE FOR ESOPHAGEAL CANCER 2025 ·Diseases of the Esophagus ·(unknown),David van Klaveren,Sjoerd M. Lagarde,Hester F. Lingsma,Bianca Mostert,Camiel Rosman,(unknown),Jan Willem T. Dekker,Henk H. Hartgrink,Joos Heisterkamp,Ewout A. Kouwenhoven,Grard A. P. Nieuwenhuijzen,(unknown),Johanna van Sandick,Meindert N. Sosef,Edwin van der Zaag,Jan van Lanschot,Bas P. L. Wijnhoven	0
3	Early‐life prediction of school‐age asthma among recurrent Wheezers in preschoolers: The WHEEP study 2025 ·Pediatric Allergy and Immunology ·(unknown),Enrica Mancino,(unknown),Marianne Brouwer,Eric de Groot,(unknown),Peter Merkus,Laetitia E.M. Niers,Anja Vaessen‐Verberne,David van Klaveren,(unknown),(unknown),(unknown),Liesbeth Duijts	1
4	Prevalence, incidence, and mortality of inflammatory bowel disease in the Netherlands: development and external validation of machine learning models 2025 ·Journal of Crohn s and Colitis ·(unknown),Nikki van Leeuwen,David van Klaveren,(unknown),(unknown),(unknown),(unknown),(unknown),Rachel West,Desirée van Noord	2
5	PREVENTION OF INCISIONAL HERNIA WITH PROPHYLACTIC ONLAY AND SUBLAY MESH REINFORCEMENT VERSUS PRIMARY SUTURE ONLY IN MIDLINE LAPAROTOMIES (PRIMA): LONG-TERM OUTCOMES OF A MULTICENTRE, DOUBLE-BLIND, RANDOMISED CONTROLLED TRIAL 2024 ·British journal of surgery ·(unknown),Dimitri Sneiders,(unknown),(unknown),David van Klaveren,E.G.J.M. Pierik,Daniel Reim,Lucas Timmermans,R. Fortelny,(unknown),Gert‐Jan Kleinrensink,Pieter J. Tanis,Johan F. Lange,Johannes Jeekel,(unknown)	0
6	Number of life-years lost at the time of diagnosis and several years post-diagnosis in patients with solid malignancies: a population-based study in the Netherlands, 1989–2019 2023 ·EClinicalMedicine ·(unknown),David van Klaveren,Otto Visser,Matthias A.W. Merkx,Hester F. Lingsma,V.E.P.P. Lemmens,Avinash G. Dinmohamed	1
7	Can Machine Learning Aid the Selection of Percutaneous vs Surgical Revascularization? 2023 ·Journal of the American College of Cardiology ·Kai Ninomiya,Shigetaka Kageyama,Hiroki Shiomi,(unknown),Shinichiro Masuda,Pruthvi C. Revaiah,Scot Garg,Neil O’Leary,David van Klaveren,Takeshi Kimura,Yoshinobu Onuma,Patrick W. Serruys	15
8	Personalised decision making to predict absolute metastatic risk in cutaneous squamous cell carcinoma: development and validation of a clinico-pathological model 2023 ·EClinicalMedicine ·(unknown),(unknown),(unknown),Zoe C Venables,Harmen J.G. van de Werken,Domenico Bellomo,David van Klaveren,Antien L. Mooyaart,Loes M. Hollestein,Marlies Wakkee	11
9	Integrated care in patients with atrial fibrillation- a predictive heterogeneous treatment effect analysis of the ALL-IN trial 2023 ·PLoS ONE ·(unknown),Geert‐Jan Geersing,(unknown),Martin E W Hemels,Michiel Rienstra,Isabelle C. Van Gelder,Maarten van Smeden,David van Klaveren,David M. Kent,Frans H. Rutten,Sander van Doorn	9
10	A standardized framework for risk-based assessment of treatment effect heterogeneity in observational healthcare databases 2023 ·npj Digital Medicine ·(unknown),David van Klaveren,Patrick Ryan,Ewout W. Steyerberg,David M. Kent,Peter R. Rijnbeek	7
11	Development and validation of self-monitoring auto-updating prognostic models of survival for hospitalized COVID-19 patients 2022 ·Nature Communications ·Todd Levy,Kevin Coppa,(unknown),Douglas P. Barnaby,Marc d. Paradis,Stuart L. Cohen,(unknown),David van Klaveren,David M. Kent,Karina W. Davidson,Jamie S. Hirsch,Theodoros P. Zanos	11
12	Impact of waiting time on post-transplant survival for recipients with hepatocellular carcinoma: A natural experiment randomized by blood group 2022 ·JHEP Reports ·Berend R. Beumer,Wojciech G. Polak,Robert A. de Man,Herold J. Metselaar,David van Klaveren,Jeremy A. Labrecque,Jan N.M. IJzermans	6
13	Graphical calibration curves and the integrated calibration index (ICI) for competing risk models 2022 ·SHILAP Revista de lepidopterología ·Peter C. Austin,Hein Putter,Daniele Giardiello,David van Klaveren	21
14	Endovascular versus neurosurgical aneurysm treatment: study protocol for the development and validation of a clinical prediction tool for individualised decision making 2022 ·BMJ Open ·(unknown),Bob Roozenbeek,Simone A. Dijkland,Rúben Dammers,Pieter‐Jan van Doormaal,Mathieu van der Jagt,David van Klaveren,Diederik W.J. Dippel,Hester F. Lingsma	2
15	External Validations of Cardiovascular Clinical Prediction Models: A Large-Scale Review of the Literature 2021 ·Circulation Cardiovascular Quality and Outcomes ·Benjamin S. Wessler,Jason Nelson,(unknown),(unknown),Gaurav Gulati,(unknown),Ben Van Calster,David van Klaveren,Esmée Venema,Ewout W. Steyerberg,Jessica K. Paulus,David M. Kent	39
16	The evolution of the loss of life expectancy in patients with chronic myeloid leukaemia: a population‐based study in the Netherlands, 1989–2018 2021 ·British Journal of Haematology ·(unknown),David van Klaveren,(unknown),Eduardus F. M. Posthuma,Otto Visser,Peter E. Westerweel,Jeroen J. W. M. Janssen,Nicole M. A. Blijlevens,Avinash G. Dinmohamed	14
17	Graphical calibration curves and the integrated calibration index (ICI) for survival models 2020 ·Statistics in Medicine ·Peter C. Austin,Frank E. Harrell,David van Klaveren	105
18	Predictive approaches to heterogeneous treatment effects: a systematic review 2019 ·medRxiv ·(unknown),Jessica K. Paulus,Gowri Raman,John B. Wong,Ewout W. Steyerberg,Peter R. Rijnbeek,David M. Kent,David van Klaveren	0
19	The value of tumor-stroma ratio as predictor of pathologic response after neoadjuvant chemoradiotherapy in esophageal cancer 2019 ·Clinical and Translational Radiation Oncology ·Gabi W. van Pelt,(unknown),Irene M. Lips,Femke P. Peters,David van Klaveren,Jurjen J. Boonstra,Wobbe O. de Steur,Rob A.�E.�M. Tollenaar,Arantza Fariña Sarasqueta,Wilma E. Mesker,Marije Slingerland	24
20	Preterm neonates benefit from low prophylactic platelet transfusion threshold despite varying risk of bleeding or death 2019 ·Blood ·Susanna F. Fustolo‐Gunnink,Karin Fijnvandraat,David van Klaveren,Simon Stanworth,Anna Curley,Wes Onland,Ewout W. Steyerberg,(unknown),(unknown),Christian V. Hulzebos,(unknown),Willem P. de Boode,Enrico Lopriore,Johanna G. van der Bom	46

About David van Klaveren

David van Klaveren is a scholar working on Statistics and Probability, Cardiology and Cardiovascular Medicine and Emergency Medicine, having authored 121 papers that have together received 4.5k indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (23 papers), Coronary Interventions and Diagnostics (20 papers) and Statistical Methods in Clinical Trials (11 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (2.1k citations), Internal Medicine (224 citations) and Statistics and Probability (377 citations). David van Klaveren has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Ewout W. Steyerberg, David M. Kent, Patrick W. Serruys, Antonio Colombo, Yvonne Vergouwe, Gregg W. Stone, Yoshinobu Onuma, Peter C. Austin, Stephan Windecker and Marco Valgimigli. Their work appears in journals such as The Lancet, Nature Communications and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact